Hoppa till innehållet

Redeye: Strax - Soft topline and more write-downs

Redeye updates on Strax following Q4 results, with weaker than expected topline and additional inventory write-offs. The company's outlook remains uncertain due to persistent challenges in the underlying market, leading to adjustments in our estimates and a downward revision of the valuation range.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Source:MFN
Tillbaka

Det verkar som att du använder en annonsblockerare

Om du är prenumerant behöver du logga in för att fortsätta. Vill du bli prenumerant kan du läsa Di Digitalt för 197 kr inkl. moms de första 3 månaderna.

spara
1180kr
Prenumerera